,,iii  #aaf? ,,congress  #a/ ,session   
,s4 ,,res4 #beh  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,june #bj1 #bjai,mr4  
,da9es 7= himself1 ,mr4 ,m>key1 ,ms4    
,coll9s1 ,mr4 ,van ,holl51 & ,ms4 ,w>r57
 submitt$ ! foll[+ resolution2 :i* 0    
consid]$ & agre$ to  ,,resolution       
,express+ support = ! designation ( ,may
 #bjai z ,national ,bra9 ,tumor ,aw>5ess
 ,mon?4  ,:]eas an e/imat$ #hf1igj new  
cases ( prim>y bra9 tumors are expect$  
to be diagnos$ 9 ! ,unit$ ,/ates dur+   
cal5d> ye> #bjai2 ,:]eas p$iatric bra9  
tumors are ! lead+ cause ( dea? f canc] 
9 *ildr5 "u ! age ( #ai2 ,:]eas ! av]age
 survival rate 9 ! ,unit$ ,/ates = all  
malignant bra9 tumor pati5ts is only #ce
 p]c5t2 ,:]eas1 9 #bjai1 an e/imat$     
#af1hcj p 9 ! ,unit$ ,/ates w die z a   
result ( a malignant bra9 tumor2 ,:]eas 
bra9 tumors may be malignant or b5ign1 b
 c be life-?reat5+ 9 ei!r case2 ,:]eas  
ne>ly #gjj1jjj p 9 ! ,unit$ ,/ates are  
curr5tly liv+ ) a bra9 tumor2 ,:]eas    
treatm5t ( bra9 tumors is complicat$ by 

! fact t !re are m ?an #acj diff]5t     
types ( bra9 tumors2 ,:]eas ! treatm5t &
 removal ( bra9 tumors pres5t           
significant *all5ges due to ! uniquely  
complex & fragile nature ( ! bra92      
,:]eas bra9 tumors affect ! prim>y organ
 9 ! human body t controls n only       
cognitive ability1 b ! actions ( e o!r  
organ & limb 9 ! body1 lead+ to bra9    
tumors be+ describ$ z a disease t       
affects ! :ole individual2 ,:]eas bra9  
tumor rese>* is support$ by a numb] (   
private1 nonpr(it rese>* f\ndations & by
 ,f$]al m$ical rese>* in/itutions2      
,:]eas basic rese>* may fuel advancem5ts
 & developm5t ( new treatm5ts = bra9    
tumors2 ,:]eas ob/acles to ! developm5t 
( new treatm5ts = bra9 tumors rema91 &  
!re are limit$ /rategies = ! scre5+ or  
e>ly detection ( bra9 tumors2 ,:]eas1   
despite ! high numb] ( individuals      
diagnos$ ) a bra9 tumor e ye> & !       
deva/at+ prognoses = su* individuals1   
only #e drugs & #a m$ical device are    
approv$ by ! ,food & ,drug ,adm9i/ration

 to treat bra9 tumors2 ,:]eas !         
mortality rates associat$ ) bra9 tumors 
h *ang$ little dur+ ! pa/ #cj ye>s2     
,:]eas !re is a ne$ = great] public     
aw>5ess ( bra9 tumors1 includ+ !        
difficulties associat$ ) rese>* on ^!   
tumors & ! opportunities = advances 9   
bra9 tumor rese>* & treatm5t2 & ,:]eas  
,may #bjai1 dur+ :i* bra9 tumor         
advocates nationwide unite 9 aw>5ess1   
outrea*1 & advocacy activities1 is an   
appropriate mon? to recognize z         
,national ,bra9 ,tumor ,aw>5ess ,mon?3  
,n[1 !re=e1 be x  ,t ! ,s5ate-- 7#a7    
supports ! designation ( ,may #bjai z   
,national ,bra9 ,tumor ,aw>5ess ,mon?2  
7#b7 enc\rages increas$ public aw>5ess (
 bra9 tumors to honor ^? individuals :o 
h lo/ _! lives to ?is deva/at+ disease  
or curr5tly live ) a bra9 tumor         
diagnosis2  7#c7 supports ef=ts to      
develop bett] treatm5ts = bra9 tumors t 
w improve ! quality ( life & ! long-t]m 
prognoses ( ^? individuals diagnos$ ) a 
bra9 tumor2  7#d7 expresses its support 

= ^? individuals :o are battl+ bra9     
tumors1 z well z ! families1 fri5ds1 &  
c>egiv]s ( ^? individuals2 &  7#e7 urges
 a collaborative approa* to bra9 tumor  
rese>*1 :i* is a promis+ means ( advanc+
 und]/&+ (1 & treatm5t =1 bra9 tumors4